Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-012000
Filing Date
2021-02-18
Accepted
2021-02-18 17:40:19
Documents
1
Period of Report
2021-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5591
  Complete submission text file 0001209191-21-012000.txt   7143
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 BRYANT STREET, #517 PALO ALTO CA 94301
Business Address 555 BRYANT STREET, #517 PALO ALTO CA 94301 650-888-8161
Longevity Fund 2 LP (Reporting) CIK: 0001708655 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40030 | Film No.: 21650869